The DOI matches its Crossref record; 146 of the 147 references it cites were found in a registry or an index.
Aβ Oligomers – a decade of discovery
Open accessAbstract
Converging lines of evidence suggest that progressive accumulation of the amyloid β‐protein (Aβ) plays a central role in the genesis of Alzheimer’s disease, but it was long assumed that Aβ had to be assembled into extracellular amyloid fibrils to exert its cytotoxic effects. Over the past decade, data have emerged from the use of synthetic Aβ peptides, cell culture models, β‐amyloid precursor protein transgenic mice and human brain to suggest that pre‐fibrillar, diffusible assemblies of Aβ are also deleterious. Although the precise molecular identity of these soluble toxins remains unsettled, accumulating evidence suggests that soluble forms of Aβ are indeed the proximate effectors of synapse loss and neuronal injury. Here we review recent progress in understanding the role of soluble oligomers in Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recent studies have shown that the soluble Aβ oligomers are more neurotoxic both in vitro and in vivo.5−8”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For the preformed Aβ42 fibrils, no significant cell toxicity was observed in either the absence or presence of Cu2+ (Figure 9, lanes 1 and 2), supporting the previously reported diminished toxicity of Aβ42 fibrils.5,7,54−56”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, recent in vivo studies have shown that soluble Aβ oligomers are more neurotoxic than amyloid plaques and most likely responsible for synaptic dysfunction and memory loss in AD.7–11”
From The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity (2013) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“However, recent in vivo studies have shown that the soluble Aβ oligomers are possibly more neurotoxic than amyloid plaques,14–17 and are likely responsible for synaptic dysfunction and memory loss in AD patients and AD animal models.18–21”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“which was also shown to form neurotoxic soluble Aβ oligomers.18–20”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“This is confirmed by the decreased cell survival of 44±8% in presence of soluble Aβ42 oligomers (Figure 11, lane 2), supporting the increased neurotoxicity of Aβ42 oligomers versus Aβ42 fibrils.16,19”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“the Aβ42 peptide was employed in these studies because it was shown to form neurotoxic soluble Aβ oligomers.5,8,48”
From Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity (2014) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 4×
“…performance in a hippocampaldependent contextual fear conditioning assay, decreased spine density in the dentate gyrus, and impairment of long-term potentiation (LTP) at ages long before the first apparent detection of Ab dodecamer (Dineley et al. 2002; Jacobsen et al. 2006; Lesne et al. 2006).”
BackgroundInfluentialRetractedCorder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Self-citationTriple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 3×
“The initial cleavage leading to amyloid b-protein (Ab) production is mediated by the aspartyl protease, b-secretase (also called b-amyloid cleaving enzyme-1, BACE-1), and occurs immediately N-terminal to the Ab domain, simultaneously generating APPsb and the membranetethered C-terminal fragment, C99 (Vassar et al. 199…”
Background
Flagged first, then by citations
1 of the 147 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Selkoe D. J., 2003, Annu. Rev. Pharmacol. Toxicol., 545
- Shankar G. M., 2007, Natural oligomers of the Alzheimer amyloid beta‐protein induce hippocampal synapse loss but can be neutralized by antibodies and small molecules, J. Neurosci.
Cited by
Sorted by citations
Items 901–1,000 of 1,010
Human Amylin: From Pathology to Physiology and Pharmacology
Ling, W., Huang, Y., Qiao, Y.-C., Zhang, X., & Zhao, H. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190328111833 · Cited by 37
Tajiri, M., Yamada, R., Hotsumi, M., Makabe, K., & Konno, H. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113289 · Cited by 37
Bett, C. K., Serem, W. K., Fontenot, K. R., Hammer, R. P., & Garno, J. C. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn900019r · Cited by 38
Stravalaci, M., Beeg, M., Salmona, M., & Gobbi, M. (2010) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2010.10.038 · Cited by 36
Immunological Origin and Functional Properties of Catalytic Autoantibodies to Amyloid β Peptide
Paul, S., Planque, S. A., & Nishiyama, Y. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9414-5 · Cited by 36
Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage
Bate, C., & Williams, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.030 · Cited by 38
Paranjape, G. S., Terrill, S. E., Gouwens, L. K., Ruck, B. M., & Nichols, M. R. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9424-6 · Cited by 39
Barcelo, A. A. R., Gonzalez‐Velasquez, F. J., & Moss, M. A. (2009) · Journal of Biological Engineering · doi:10.1186/1754-1611-3-5 · Cited by 37
LPYFDa Neutralizes Amyloid-β-Induced Memory Impairment and Toxicity
Granic, I., Masman, M. F., Mulder, C. K., Nijholt, I. M., Naudé, P., de Haan, A., Borbély, E., Penke, B., Luiten, P. G. M., & Eisel, U. L. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1297 · Cited by 37
Leggio, G. M., Catania, M. V., Puzzo, D., Spatuzza, M., Pellitteri, R., Gulisano, W., Torrisi, S. A., Giurdanella, G., Piazza, C., Impellizzeri, A. A. R., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.007 · Cited by 37
Galant, N. J., Bugyei‐Twum, A., Rakhit, R., Walsh, P. J., Sharpe, S. J., Arslan, P. E., Westermark, P., Higaki, J. N., Torres, R., Tapia, J. R., et al. (2016) · Scientific Reports · doi:10.1038/srep25080 · Cited by 37
Sweet, R. A., MacDonald, M. L., Kirkwood, C. M., Ding, Y., Schempf, T. A., Jones-Laughner, J., Kofler, J., Ikonomović, M. D., López, O. L., Garver, M. E., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.056580 · Cited by 36
Salvadores, N., Searcy, J. L., Holland, P. R., & Horsburgh, K. J. (2017) · Clinical Science · doi:10.1042/cs20170962 · Cited by 37
Cheng, L., Chen, Y., Guo, D., Zhong, Y., Li, W., Lin, Y., & Miao, Y. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01097-1 · Cited by 37
Lee, H. R., Shin, H. K., Park, S. Y., Kim, H. Y., Bae, S. S., Lee, W. S., Rhim, B. Y., Hong, K. W., & Kim, C. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134486 · Cited by 36
Chojnacki, J. E., Liu, K., Saathoff, J. M., & Zhang, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.10.032 · Cited by 38
Diaryl Hydrazones as Multifunctional Inhibitors of Amyloid Self-Assembly
Török, B., Sood, A., Bag, S., Tulsan, R., Ghosh, S., Borkin, D., Kennedy, A. R., Melanson, M., Madden, R., Zhou, W., et al. (2013) · Biochemistry · doi:10.1021/bi3012059 · Cited by 36
Balakrishnan, M., Hussain, S., & Iyer, P. K. (2013) · Polymer Chemistry · doi:10.1039/c3py00680h · Cited by 36
Granic, I., Nyakas, C. J., Luiten, P. G. M., Eisel, U. L. M., Halmy, L. G., Groß, G., Schoemaker, H., Möller, A., & Nimmrich, V. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.013 · Cited by 36
Ageing Increases Vulnerability to Aβ42 Toxicity in Drosophila
Rogers, I., Kerr, F., Martinez, P., Hardy, J., Lovestone, S., & Partridge, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040569 · Cited by 41
A folding transition underlies the emergence of membrane affinity in amyloid-β
Nag, S., Sarkar, B., Chandrakesan, M., Abhyanakar, R., Bhowmik, D., Kombrabail, M. H., Dandekar, S., Lerner, E., Haas, E., & Maiti, S. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp52732h · Cited by 36
Biological basis for amyloidogenesis in Alzheimer’S disease
Андреева, Т. В., Lukiw, W. J., & Rogaev, E. I. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917020043 · Cited by 38
Esteve, C., Jones, E. A., Kell, D. B., Boutin, H., & McDonnell, L. A. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.04.002 · Cited by 36
An integrated strategy to correlate aggregation state, structure and toxicity of Aß 1–42 oligomers
Bisceglia, F., Natalello, A., Serafini, M. M., Colombo, R., Verga, L., Lanni, C., & Lorenzi, E. D. (2018) · Talanta · doi:10.1016/j.talanta.2018.05.062 · Cited by 37
Le, N. T. T., Wu, B., & Harris, D. A. (2018) · Brain Pathology · doi:10.1111/bpa.12694 · Cited by 36
Hotsumi, M., Tajiri, M., Nikaido, Y., Sato, T., Makabe, K., & Konno, H. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.06.052 · Cited by 36
Aducanumab and Its Effects on Tau Pathology: Is This the Turning Point of Amyloid Hypothesis?
Silvestro, S., Valeri, A., & Mazzon, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042011 · Cited by 37
Zhang, S., Wei, D., Lv, S., Wang, L., An, H., Shao, W., Wang, Y., Huang, Y., Peng, D., & Zhang, Z. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220532 · Cited by 36
Hieke, M., Neß, J., Steri, R., Dittrich, M., Greiner, C., Werz, O., Baumann, K., Schubert‐Zsilavecz, M., Weggen, S., & Zettl, H. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1003073 · Cited by 36
Staton, S. J. R., Jones, P. V., Ku, G., Gilman, S. D., Kheterpal, I., & Hayes, M. A. (2012) · The Analyst · doi:10.1039/c2an35138b · Cited by 36
Kirkwood, C. M., Ciuchta, J., Ikonomovic, M. D., Fish, K. N., Abrahamson, E. E., Murray, P. S., Klunk, W. E., & Sweet, R. A. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31829ecc89 · Cited by 35
New diagnostic concepts in Alzheimer's disease
Watkin, A., Sikdar, S., Majumdar, B., & Richman, A. V. (2013) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.112.010462 · Cited by 35
Aβ Mediated Diminution of MTT Reduction—An Artefact of Single Cell Culture?
Rönicke, R., Klemm, A., Meinhardt, J., Schröder, U. H., Fändrich, M., & Reymann, K. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003236 · Cited by 36
Angiotensins and Alzheimer's disease: a bench to bedside overview
Kehoe, P. G. (2009) · Alzheimer s Research & Therapy · doi:10.1186/alzrt3 · Cited by 34
Targeted Magnetic Nanoparticles for Remote Magnetothermal Disruption of Amyloid‐β Aggregates
Loynachan, C. N., Romero, G., Christiansen, M. G., Chen, R., Ellison, R., O’Malley, T. T., Froriep, U. P., Walsh, D. M., & Anikeeva, P. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500487 · Cited by 35
Self-citationWaldron, A., Wintmolders, C., Bottelbergs, A., Kelley, J. B., Schmidt, M. E., Stroobants, S. G., Langlois, X., & Staelens, S. G. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0158-6 · Cited by 34
Zhang, Z., Li, X., Li, D., Luo, M., Li, Y., Li, S., & Jiang, X. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.4004 · Cited by 35
Detecting Aβ*56 Oligomers in Brain Tissues
Sherman, M. A., & Lesné, S. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-744-0_4 · Cited by 35
Differential regulation of neurogenesis in two neurogenic regions of APPswe/PS1dE9 transgenic mice
Niidome, T., Taniuchi, N., Akaike, A., Kihara, T., & Sugimoto, H. (2008) · Neuroreport · doi:10.1097/wnr.0b013e32830e6dd6 · Cited by 35
Temporal proteomic profile of memory consolidation in the rat hippocampal dentate gyrus
Monopoli, M. P., Raghnaill, M. N., Loscher, J. S., O’Sullivan, N. C., Pangalos, M. N., Ring, R. H., von Schack, D., Dunn, M. J., Regan, C. M., Pennington, S. R., et al. (2011) · PROTEOMICS · doi:10.1002/pmic.201100072 · Cited by 37
Does the term ‘trophic’ actually mean anti-amyloidogenic? The case of NGF
Calissano, P., Amadoro, G., Matrone, C., Ciafrè, S., Marolda, R., Corsetti, V., Ciotti, M. T., Mercanti, D., Luzio, A. D., Severini, C., et al. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.38 · Cited by 36
Jagota, S., & Rajadas, J. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0386-2 · Cited by 35
Kulikova, A. A., Makarov, A. А., & Kozin, S. A. (2015) · Molecular Biology · doi:10.1134/s0026893315020065 · Cited by 35
Jones, M. R., Dyrager, C., Hoarau, M., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., & Storr, T. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.022 · Cited by 34
Zilony, N., Rosenberg, M., Richman, M., Yehuda, R., Schori, H., Motiei, M., Rahimipour, S., Groisman, A., Segal, E., & Shefi, O. (2019) · Small · doi:10.1002/smll.201904203 · Cited by 34
Sun, J. L., Stokoe, S. A., Roberts, J. P., Sathler, M. F., Nip, K., Shou, J., Ko, K. H., Tsunoda, S., & Kim, S. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.09.005 · Cited by 36
Current and Emerging Pharmacological Targets for the Treatment of Alzheimer’s Disease
Morsy, A., & Trippier, P. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190744 · Cited by 36
Complexes of Amyloid-β and Cystatin C in the Human Central Nervous System
Mi, W., Jung, S. S., Yu, W. H., Schmidt, S. D., Nixon, R. A., Mathews, P. M., Tagliavini, F., & Levy, E. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1147 · Cited by 34
Bett, C. K., Ngunjiri, J. N., Serem, W. K., Fontenot, K. R., Hammer, R. P., McCarley, R. L., & Garno, J. C. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100045q · Cited by 35
Myelin Basic Protein Binds to and Inhibits the Fibrillar Assembly of Aβ42 in Vitro
Hoos, M. D., Ahmed, M., Smith, S. O., & Nostrand, W. E. V. (2009) · Biochemistry · doi:10.1021/bi900037s · Cited by 37
“Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders
Zampar, S., Gregorio, S. E. D., Grimmer, G., Watts, J. C., & Ingelsson, M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1436262 · Cited by 39
Fosso, M. Y., LeVine, H., Green, K. D., Tsodikov, O. V., & Garneau‐Tsodikova, S. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01478f · Cited by 33
Link, P., Wetterauer, B., Fu, Y., & Wink, M. (2015) · Planta Medica · doi:10.1055/s-0035-1545724 · Cited by 33
Involvement of paraoxonase 1 genetic variants in Alzheimer’s disease neuropathology
Leduc, V., Théroux, L., Dea, D., Robitaille, Y., & Poirier, J. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06983.x · Cited by 32
Hoey, S. E., Buonocore, F., Cox, C. J., Hammond, V. J., Perkinton, M. S., & Williams, R. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078155 · Cited by 34
Alzheimer’s Disease: Current Status of Etiopathogenesis and Therapeutic Strategies
Kh, M. I., & Kassem, L. A. A. (2011) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2011.257.272 · Cited by 33
Ai, Z., Li, C., Li, L., & Guo-hou, H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3034 · Cited by 34
Tikhonova, M. A., Amstislavskaya, T. G., Ho, Y., Akopyan, A. A., Tenditnik, M. V., Ovsyukova, M. V., Bashirzade, A. A., Dubrovina, N. I., & Aftanas, L. I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736786 · Cited by 33
Mitigating Effect of Estrogen in Alzheimer’s Disease-Mimicking Cerebral Organoid
Kim, J. Y., Mo, H., Kim, J., Kim, J. W., Nam, Y., Rim, Y. A., & Ju, J. H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.816174 · Cited by 33
Ahmad, B., Winkelmann, J., Tiribilli, B., & Chiti, F. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.10.005 · Cited by 32
Lin, C., Chang, L., Tseng, G. C., Kirkwood, C. M., Sibille, E. L., & Sweet, R. A. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00030 · Cited by 35
Interaction between Prion Protein and Aβ Amyloid Fibrils Revisited
Nieznański, K., Surewicz, K. A., Chen, S., Nieznańska, H., & Surewicz, W. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500019c · Cited by 33
Coburger, I., Hoefgen, S., & Than, M. E. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0280 · Cited by 33
Immunotherapy as treatment for Alzheimer’s disease
Hawkes, C. A., & McLaurin, J. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1535 · Cited by 33
Turn Nucleation Perturbs Amyloid β Self-Assembly and Cytotoxicity
Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.055 · Cited by 32
Cerebrospinal fluid analysis in Alzheimer’s disease: technical issues and future developments
Lista, S., Zetterberg, H., Dubois, B., Blennow, K., & Hampel, H. J. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7366-z · Cited by 34
NMR Reveals Two-Step Association of Congo Red to Amyloid β in Low-Molecular-Weight Aggregates
Pedersen, M. Ø., Mikkelsen, K., Behrens, M. A., Pedersen, J. S., Enghild, J. J., Skrydstrup, T., Malmendal, A., & Nielsen, N. C. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp108035y · Cited by 33
Purushothuman, S., Marotte, L. R., Stowe, S., Johnstone, D. M., & Stone, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059740 · Cited by 31
Metal attenuating therapies in neurodegenerative disease
Mot, A. I., Wedd, A. G., Sinclair, L., Brown, D. R., Collins, S. J., & Brazier, M. W. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.170 · Cited by 32
A Novel Perspective on Tau in Alzheimers Disease
Bonda, D., Castellani, R. J., Zhu, X., Nunomura, A., Lee, H., Perry, G. L., & Smith, M. A. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717131 · Cited by 32
Smith, D. K., He, M., Zhang, C., & Zheng, J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.006 · Cited by 34
Blood-based molecular signature of Alzheimer's disease via spectroscopy and metabolomics
Habartová, L., Králová, K., Syslová, K., Vondroušová, J., Fišar, Z., Jirák, R., Raboch, J., & Setnička, V. (2019) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2019.04.004 · Cited by 32
Anti-Alzheimer's flavanolignans from Ceiba pentandra aerial parts
Abouelela, M. E., Orabi, M. A. A., Abdelhamid, R. A., Abdelkader, M. S. A., Darwish, F., Hotsumi, M., & Konno, H. (2020) · Fitoterapia · doi:10.1016/j.fitote.2020.104541 · Cited by 32
Amyloids: Regulators of Metal Homeostasis in the Synapse
Kawahara, M., Kato‐Negishi, M., & Tanaka, K. (2020) · Molecules · doi:10.3390/molecules25061441 · Cited by 31
Xue, F., Tian, J., Yu, C., Du, H., & Guo, L. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105272 · Cited by 32
Synaptic Disruption by Soluble Oligomers in Patients with Alzheimer’s and Parkinson’s Disease
Gutierrez, B. A., & Limón, A. (2022) · Biomedicines · doi:10.3390/biomedicines10071743 · Cited by 32
Amyloid-β and Glucose Metabolism in Alzheimer's Disease
Furst, A. J., & Lal, R. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0066 · Cited by 33
Pettersson, M., Johnson, D. S., Subramanyam, C., Bales, K. R., Ende, C. W. A., Fish, B. A., Green, M., Kauffman, G. W., Lira, R., Mullins, P. B., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.059 · Cited by 32
Oxidative Stress and Alzheimer’s Disease
Singh, S. K., Castellani, R. J., & Perry, G. L. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_10 · Cited by 33
Schulze, J., Moosmayer, D., Weiske, J., Fernández‐Montalván, A. E., Herbst, C., Jung, M., Haendler, B., & Bader, B. (2014) · SLAS DISCOVERY · doi:10.1177/1087057114552398 · Cited by 30
Detrait, E., Maurice, T., Hanon, É., Leclercq, K., & Lamberty, Y. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.013 · Cited by 32
Moll, L., & Schubert, M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/384094 · Cited by 31
Zerbi, V., Jansen, D., Dederen, P. J. W. C., Veltien, A. A., Hamans, B. C., Liu, Y., Heerschap, A., & Kiliaan, A. J. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0448-8 · Cited by 30
Discovery and characterization of a mammalian amyloid disaggregation activity
Murray, A. N., Solomon, J. P., Wang, Y., Balch, W. E., & Kelly, J. W. (2010) · Protein Science · doi:10.1002/pro.363 · Cited by 31
Physical principles of filamentous protein self-assembly kinetics
Michaels, T. C. T., Liu, L. X., Meisl, G., & Knowles, T. P. J. (2017) · Journal of Physics Condensed Matter · doi:10.1088/1361-648x/aa5f10 · Cited by 31
A near atomic-scale view at the composition of amyloid-beta fibrils by atom probe tomography
Rusitzka, K. A. K., Stephenson, L. T., Szczepaniak, A., Gremer, L., Raabe, D., Willbold, D., & Gault, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-36110-y · Cited by 30
Haroon, M. M., Saba, K., Boddeda, V. H. V., Kumar, J. M., Patel, A. B., & Gopal, V. (2019) · Journal of Biosciences · doi:10.1007/s12038-018-9822-x · Cited by 31
Leng, H., Wang, Y., Wang, J., Sun, H., Sun, A., Pistolozzi, M., Zhang, L., & Yan, J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03452 · Cited by 31
Fabbro, S., Schaller, K., & Seeds, N. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07359.x · Cited by 31
Amyloid Beta-Protein and Neural Network Dysfunction
Peña‐Ortega, F. (2013) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/657470 · Cited by 31
Morphology and Secondary Structure of Stable β-Oligomers Formed by Amyloid Peptide PrP(106−126)
Walsh, P. J., Yau, J., Simonetti, K., & Sharpe, S. J. (2009) · Biochemistry · doi:10.1021/bi9007319 · Cited by 30
Amyloid Imaging in Early Detection of Alzheimer’s Disease
Nordberg, A. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000289223 · Cited by 33
Vitagliano, L., Esposito, L., Pedone, C., & Simone, A. D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.039 · Cited by 31
Pettersson, M., Johnson, D. S., Subramanyam, C., Bales, K. R., Ende, C. W. A., Fish, B. A., Green, M., Kauffman, G. W., Mullins, P. B., Navaratnam, T., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401782h · Cited by 31
Medina, M., & Ávila, J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.39 · Cited by 33
Structural and Thermodynamic Characteristics That Seed Aggregation of Amyloid-β Protein in Water
Chong, S., Park, M., & Ham, S. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct200757a · Cited by 31
Montoliu‐Gaya, L., Esquerda-Canals, G., Bronsoms, S., & Villegas, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181480 · Cited by 31
Promotion Effect of Succinimide on Amyloid Fibrillation of Hen Egg-White Lysozyme
Fan, W., Xing, L., Chen, N., Zhou, X., Yu, Y., & Liu, S. (2019) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b06958 · Cited by 31
One‐year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice
Cudennec, C. L., Faure, A., Ly, M., & Delatour, B. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00374.x · Cited by 32
Optimizing phase II of drug development for disease‐modifying compounds
Cummings, J. L. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2007.10.002 · Cited by 31
Metadata
- Authors
- Walsh, D. M., & Selkoe, D. J.
- Affiliations
- University College Dublin (IE)
- Brigham and Women's Hospital (US)
- Corresponding author
- Walsh, Dominic M.
- Selkoe, Dennis J.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-01-04
- Volume
- 101
- Issue
- 5
- Pages
- 1172-1184
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1981458288
- Cited by
- 1,938
- References
- 147
- Citations by year
- 2026: 48 · 2025: 36 · 2024: 46 · 2023: 47 · 2022: 50 · 2021: 63 · 2020: 76 · 2019: 81 · 2018: 81 · 2017: 109 · 2016: 120 · 2015: 136 · 2014: 134 · 2013: 159 · 2012: 167
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation for Neurologic Diseases
- Wellcome Trust (067660)
- National Institutes of Health
- National Institute on Aging (AG-06173)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, soluble amyloid-beta, synaptic loss, neuronal injury, amyloid fibrils, amyloid precursor protein, transgenic mouse model
- MeSH terms
- Alzheimer Disease, Humans, Male, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Structure, Secondary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
